TCL Archive Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity October 28, 2011
TCL Archive In Brief; “Sense of Urgency” In Research Is Theme of New AACR President Daniel Von Hoff April 16, 1999
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
